Affiliation:
1. Amepurva Forum’s, Nirant Institute of Pharmacy, Boramani, Solapur, Maharashtra, India
Abstract
The goal of Floating Drug Delivery Systems (FDDS) is to arrange the current emphasis on the basic flotation mechanism to attain stomach retention time. The most current advancements in FDDS are thoroughly discussed, including the formulation and physiological factors influencing stomach retention, methods for designing floating systems, and the characteristics of their classification and formulation. Since dosage forms stay in the stomach longer than conventional dosage forms, the capacity to extend and control the gastric emptying time is a major asset. Gastric emptying of dosage forms is a highly variable process. Drugs with gastroretentive systems have a much longer residence time in the stomach area, improving bioavailability, decreasing drug waste, and increasing solubility for medications that are less soluble in high pH environments. These benefits are achieved over a period of many hours. This review provides a brief overview of floating medication delivery devices
Reference23 articles.
1. Vyas SP, Roop KK. Floating DrugDelivery Concepts and Advances, First Edition, New Delhi. 2002; 196-217.
2. Jain NK. Progress in Controlled and Novel Drug Delivery Systems. First Ed. CBSS.Gopalakrishnan et al,Journal of Pharmaceutical Science and Technology. Publishers and Distributors, New Delhi,Bangalore. 2004; 3(2): 84-85.
3. Lovenish Bhardwaj, Pramod Kumar Sharma; A short review on gastro retentive formulations for stomach specific drug delivery: special emphasis on floating in situ gel systems; African journal of basic and applied sciences 3 (2011) 300-312.
4. Agyilirah GA, Green M and Ducret R. Evaluation of the gastric retention properties of a cross linked polymer coated tablet versus those of a non‐disintegrating tablets. Int J Pharm. 1991;75:241‐247.
5. Hoffman F, Pressman JH and Code CF. Controlled entry of orally administered drugs, physiological considerations. Drug Dev Ind Pharm. 1983;9:1077‐1085.